Our findings highlight the critical role of GDAP1 in preserving MCSs and the structural integrity and functional capacity of peripheral nerves and propose PPARγ as a potential drug target for GDAP1-related Charcot-Marie-Tooth disease. This evidence concerns the gene PPARG and Charcot-Marie-Tooth disease.